Caris is a leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human …

Caris Life Sciences combines the use of sophisticated tumor profiling technologies with leading edge bioinformatics capabilities to advance precision medicine in ways that only we can.

Caris Life Sciences provides patients with resources on molecular profiling, financial assistance, and personalized cancer treatment options to empower informed decisions.

Caris’ industry-leading laboratories help improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in …

With a primary focus on cancer, Caris has built a market-leading portfolio of precision medicine tools that have helped more than half a million cancer patients worldwide.

Caris helps improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in tissue or blood, plus …

Caris Assure® is a liquid biopsy that provides a minimally invasive blood test for comprehensive molecular analysis of tumor biomarkers, guiding personalized cancer therapy.

The Caris Molecular Profiling Report delivers high impact results, including potentially relevant, actionable clinical information, in an easy-to-interpret format.

Reach out to Caris Life Sciences for customer support at 1.888.979.8669, billing inquiries at 1.877.630.6223, or visit our corporate headquarters in Irving, TX.

Explore how a convergence of rapid advances in next-generation sequencing, machine learning, artificial intelligence and computing power has driven Caris research, collaborations and inventions.